Minocycline HCl

Pharmaceutical Minocycline HCl Raw Powder CAS 13614-98-7

 

  • Ainm toraidh:

    Minocycline HCl

  • Ìre:

    Pharmaceutical grade

  • Feartan:

    yellow powder

  • Pacadh:

    25kg/bag/drum

  • MOQ:

    1 ton

  • Stòradh:Àite tioram fionnar
  • Beatha sgeilp:2 bhliadhna


Mion-fhiosrachadh

Tagaichean

Tuairisgeul toraidh

 

Moxifioxacin hydrochlodde is one of the two new fluoroquinolonecarboxylic acid antibiotics introduced in 1999 for the treatment of respiratory tract infections such as community-acquired pneumonia, acute exacerbations of bronchitis or acute sinusitis. Moxifloxacin can be synthesized through a 12 step sequence from the classical 4-quinolone-3-carboxylic acid template. Some advantages of Moxifloxacin over Ciprofloxacin, another of Bayer's launched quinolones, have been shown, i.e. an enhanced activity against Gram-positive bacteria (Streptococcus pneumoniae, Clostndium pneumoniae), a favorable pharmacokinetic profile (good tissue penetration and plasma concentrations above MICs) and a lack of phototoxicity (UVA irradiation). 

Taisbeanadh bathar
<trp-post-container data-trp-post-id='7515'>Minocycline HCl</trp-post-container><trp-post-container data-trp-post-id='7515'>Minocycline HCl</trp-post-container><trp-post-container data-trp-post-id='7515'>Minocycline HCl</trp-post-container><trp-post-container data-trp-post-id='7515'>Minocycline HCl</trp-post-container>
Feartan

 

Moxifloxacin can be used to treat social acquired pneumonia caused by Staphylococcus aureus, influenza bacilli, pneumococcus, acute attack of chronic bronchitis, acute sinusitis, etc. It belongs to the fourth generation of quinolone antibiotics and is a new generation of broad spectrum antibiotics. It has strong antimicrobial activity against common respiratory pathogens such as Streptococcus pneumoniae, Haemophilus, Morahan catarrhalis and some Staphylococcus aureus, especially Streptococcus pneumoniae. It is clinically used to treat acute sinus adenitis, acute exacerbation of chronic bronchitis) community acquired pneumonia, as well as non-complications of skin and soft tissue 

Iarrtas

 

Moxifloxacin Hydrochloride is a fluoroquinolone antibiotic developed by Bayer Pharmaceuticals (Germany.) It can be used to treat community-acquired pneumonia caused by Staphylococcus aureus, baccilus, pneumococcus, mucositis Moraxella, and Klebsiella pneumoniae, acute chronic bronchitis attacks, and acute sinusitis. For the treatment of adult bacterial lung infections, paranasal sinus, skin, and abdominal cavity. Also used to treat community-acquired pneumonia, chronic bronchitis, urogenital infection, and acute sinusitis.

 

Buannachdan

 

Tha mòran fhactaraidhean àrd-inbhe againn le co-obrachadh domhainn, a bheir dhut toraidhean àrd-inbhe agus prìsean farpaiseach. Agus is urrainn dhuinn cuideachd lasachaidhean a thoirt seachad airson mòr-cheannach. Tha an ùine lìbhrigidh timcheall air 3-20 latha às deidh dearbhadh pàighidh.

<trp-post-container data-trp-post-id='7515'>Minocycline HCl</trp-post-container><trp-post-container data-trp-post-id='7515'>Minocycline HCl</trp-post-container><trp-post-container data-trp-post-id='7515'>Minocycline HCl</trp-post-container><trp-post-container data-trp-post-id='7515'>Minocycline HCl</trp-post-container>
Sònrachadh

 

Items

Inbhe

Toradh
Coltas Yellow crystalline powder A 'gèilleadh
Crystallinity A 'gèilleadh A 'gèilleadh
Aithneachadh A 'gèilleadh A 'gèilleadh
Water 4.3~8.0% 6.7%
PH 3.4-4.5 3.9
Related substances Epiminocycline ≤1.2%
Any other impurity ≤1.2%
Total impurities other than epiminocycline ≤2.0%
0.47%
0.47%
1.5%
Residue on ignition ≤0.15% 0.09%
Heavy metals ≤50ppm <50ppm
Residual solvent Carbinol ≤0.3% <0.08%
Assay 890ug/mg~950ug/mg 900ug/mg
Assay 96.0~102.0% (Drying basis) 98.4%
Co-dhùnadh Complies with USP38 standard.

 

 

Eòlas toraidh:

 

Minocycline Hydrochloride is a semisynthetic tetracycline class,broad-spectrum antibiotics in the tetracycline class of antibiotics,the product of the strongest activity.To gram-positive bacteria including tetracycline resistance of staphylococcus aureus,streptococcus and gram-negative bacteria such as gonorrhea netheril bacteria have a strong role; For chlamydia trachomatis and dissolving urea mycoplasma also has better inhibition.

Minocycline HCL can combine with tRNA to achieve bacteriostatic effect.
Streptococcus and leather are Neisseria gonorrhoeae Gram-negative bacteria in a very strong role; the role of gram negative bacilli is generally weak; have good inhibitory effect on Chlamydia trachomatis and ureaplasma.

 

Gluasad agus pàigheadh

 

&lt;trp-post-container data-trp-post-id=&#039;7515&#039;&gt;Minocycline HCl&lt;/trp-post-container&gt;

 

 

Ceistean Cumanta

1. An e factaraidh no companaidh malairt a th 'annad?
Tha sinn nar companaidh a tha ag amalachadh gnìomhachas agus malairt, a’ toirt seachad seirbheis aon-stad. Dh’ fhaodadh gabhail ri OEM.

2. A bheil thu a 'toirt seachad samples? A bheil e an-asgaidh no a bharrachd?
Saor an-asgaidh samples.The shampall cìs bathair feumar pàigheadh ​​le ur taobh.

3. A bheil teisteanasan sam bith agad co-cheangailte ri smachd càileachd?
Teisteanas ISO 9001: 2008 gus dèanamh cinnteach à càileachd.

4. Dè a bu chòir dhomh a thoirt seachad gus luachan fhaighinn?
Bidh Pls ag innse dhuinn mun t-seòrsa toraidh a dh’ fheumas tu, meud òrduigh, seòladh agus riatanasan sònraichte. Thèid an luachan a dhèanamh airson do iomradh ann an ùine.

5. Dè an seòrsa dòigh pàighidh as fheàrr leat? Dè an seòrsa teirmean ris an tèid gabhail?
Cumhachan Lìbhrigeadh ris an deach gabhail: FOB, CFR, CIF, EXW;
Airgead pàighidh ris an deach gabhail: USD;
Seòrsa Pàighidh ris an deach gabhail: T / T, Western Union; Paypal, Dearbhadh Malairt.
Cànan air a labhairt: Beurla.

 

Ma tha ùidh agad anns na stuthan againn, faodaidh tu roghnachadh d’ fhiosrachadh fhàgail an seo, agus bidh sinn ann an conaltradh riut a dh’ aithghearr.


Sgrìobh do theachdaireachd an seo agus cuir thugainn e